65,437 trials
Cancer
Primary: Maximum Tolerated Dose (MTD) of Eribulin Mesylate of E7389 in Combination With Carboplatin in Subjects With Advanced Solid Tumors. — 1.4; 1.1; 1.1 mg/m^2
Tourette's Syndrome · Tic Disorders
Primary: Calculating Difference Between Means (Baseline and Endpoint Scores on the Yale Global Tic Severity Scale Subscales) — 15.82; 9.73; 12.36; 7.00 units on a scale — p=<.05
Primary Immune Deficiency
Primary: Annualized Rate of Clinically Documented Serious Bacterial Infections (SBIs) (MITT Population) — 0.00 SBIs per subject year
Osteoarthritis, Knee
Primary: Pain( Visual Analog Scale ) — 2.3; 6.4 units on a scale
Opioid Dependence
Primary: Retention in Treatment — 7; 5; 6 participants — p=0.32
Partial Epilepsies
Primary: Number of Subjects Reporting at Least 1 Treatment-Emergent Adverse Event (TEAE) During the Study — 64 subjects
Diabetes Mellitus, Type 2
Primary: Maximum Plasma Concentration (Cmax) — 901.82; 770.52 ng/ml
Schizophrenia · Hallucinations
Primary: Hallucination Change Score - Right (HCS-right) — 7.78; 9.30 units on a scale
Multiple Myeloma
Primary: Immune Response — 7 Particpants
Parkinson Disease
Primary: Change From Baseline in Unified Parkinsons Disease Rating Scale (UPDRS) Parts II+III Score at Week 18 — -13.807; -13.047 Units on a scale — p=<0.0001
Ischemic Stroke · Intracranial Hemorrhage · Transient Ischemic Attack
Primary: Feasibility of Intervention (Ability to Reach Patients at 3 Months) — 16; 10 number of patients contacted
HIV Infections
Primary: Percentage of Tested Participants Newly Diagnosed as HIV Infected — 6; 3 percentage of tested that are positive
Orthopaedic Traumatic Open Fractures
Primary: Healing of Orthopaedic Trauma Open Fractures — 3.2; 4.0 use days
Venous Thrombosis
Primary: Percentage of Participants With Symptomatic Recurrent Venous Thromboembolism [VTE] (i.e. the Composite of Recurrent Deep Vein Thrombosis [DVT] or Fatal or Non-fatal…
Depression · Heart Diseases
Primary: Hamilton Depression Rating Scale — -7.5; -6.1; -4.5 Raw changes in Ham-D scores